Novello, S <br/><br/>
Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer.  [electronic resource] 

 -  British journal of cancer  Nov 2009 
 - 1543-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-1827 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjc.6605346  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Female<br/>Humans<br/>Indoles--administration & dosage<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Pyrroles--administration & dosage<br/>Sunitinib